TORONTO, April 22,
2025 /CNW/ - DRI Healthcare Trust (TSX: DHT.UN) (TSX:
DHT.U) (the "Trust"), a global leader in providing financing to
advance innovation in the life sciences industry, announces
that it will hold a conference call to discuss its first quarter
2025 financial results on Tuesday, May 13,
2025, at 8:00 a.m. ET. The
Trust will report its financial results on Monday, May 12, 2025, after market close.
All interested parties may join the conference call by dialling
416-945-7677 or 1-888-699-1199 approximately 15 minutes prior to
the call to secure a line. You will be put on hold until the
conference call begins. To join the conference call without
operator assistance, you may register and enter your phone number
at https://emportal.ink/4lgQeY1 to receive an instant
automated callback. A question-and-answer session will follow
management's prepared remarks, at which time the operator will
provide instructions for qualified equity analysts to submit
questions.
A live webcast of the conference call, including a slide
presentation, will be available
at https://app.webinar.net/WbKDXPYGBJp. Please connect at
least 15 minutes prior to the conference call to ensure adequate
time for any software download that may be required to join the
webcast. The webcast will be archived on the Trust's website
following the call date.
About DRI Healthcare Trust
The Trust is managed by DRI Capital Inc., a pioneer in global
pharmaceutical royalty monetization. Since its initial public
offering in 2021, the Trust has deployed more than US$1.0 billion, acquiring more than 25 royalties
on 20-plus drugs, including Eylea, Orserdu, Omidria, Spinraza,
Stelara, Vonjo, Zejula and Zytiga. The Trust's units are listed and
trade on the Toronto Stock Exchange in Canadian dollars under the
symbol "DHT.UN" and in U.S. dollars under the symbol "DHT.U". To
learn more, visit drihealthcare.com or follow us on LinkedIn.
SOURCE DRI Healthcare Trust
